Cover Image
Market Research Report
Product code
883719

Europe PCR Multiplex Assays Market - Industry Trends & Forecast to 2026

Published: | Data Bridge Market Research Private Limited | 350 Pages | Delivery time: 3-5 business days

Price

Back to Top
Europe PCR Multiplex Assays Market - Industry Trends & Forecast to 2026
Published: June 1, 2019
Data Bridge Market Research Private Limited
Content info: 350 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

Europe PCR multiplex assays market is projected to register a healthy CAGR in the forecast period 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (Germany, France, U.K., Italy, Spain, Ireland, Austria, Belgium, Netherlands, Switzerland, Rest of Europe)

Some of the major factors contributing to the growth of the Europe market:

  • Technological advancement
  • Increasing R&D expenditure in health care industry

Market Players:

The key market players for Europe PCR multiplex assays market are listed below:

  • Thermo Fisher Scientific Inc.
  • Luminex Corporation
  • BD
  • QIAGEN
  • Agilent Technologies Inc.
  • Meso Scale Diagnostics, LLC
  • Randox Laboratories Ltd.
  • Bio-Techne, Seegene Inc.
  • Olink
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam Plc
  • Quanterix
  • Sysmex Corporation
  • Siemens
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc.
  • Diasorin
  • Abbott
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc.
  • Eurofins Scientific
  • Agena Bioscience, Inc.
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE PCR MULTIPLEX ASSAYS MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 EUROPE PCR MULTIPLEX ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 MARKET APPLICATION COVERAGE GRID
  • 2.9 DBMR VENDOR SHARE ANALYSIS
  • 2.10 MULTIVARIATE MODELING
  • 2.11 PRODUCTS LIFELINE CURVE
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 TECHNOLOGICAL ADVANCEMENTS OF PCR MULTIPLEX ASSAYS
    • 3.1.2 INTRODUCTION OF NOVEL AUTOMATED SYSTEMS
    • 3.1.3 GROWING RESEARCH AND DEVELOPMENT FOR DRUG DISCOVERY
    • 3.1.4 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
  • 3.2 RESTRAINTS
    • 3.2.1 HIGH COST OF THE MULTIPLEX ASSAYS
    • 3.2.2 STRINGENT REGULATIONS AND STANDARDS
  • 3.3 OPPORTUNITIES
    • 3.3.1 GROWING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
    • 3.3.2 BUSINESS EXPANSION FOR DEVELOPMENT OF PCR MULTIPLEX ASSAYS
  • 3.4 CHALLENGE
    • 3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES

  • 6.1 OVERVIEW
  • 6.2 REAGENTS & CONSUMABLES
  • 6.3 INSTRUMENTS & ACCESSORIES
  • 6.4 SOFTWARE AND SERVICES

7 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 CLINICAL DIAGNOSTICS
    • 7.2.1 CANCER
    • 7.2.2 CARDIOVASCULAR DISEASES
    • 7.2.3 RESPIRATORY DISEASES
    • 7.2.4 METABOLISM & ENDOCRINOLOGY DISORDERS
    • 7.2.5 NERVOUS SYSTEM DISORDERS
    • 7.2.6 AUTOIMMUNE DISEASES
    • 7.2.7 ALLERGIES
    • 7.2.8 OTHERS
  • 7.3 RESEARCH & DEVELOPMENT
    • 7.3.1 DRUG DISCOVERY & DEVELOPMENT
    • 7.3.2 BIOMARKER DISCOVERY & VALIDATION

8 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 CLINICAL LABORATORIES
  • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.5 RESEARCH INSTITUTES
  • 8.6 OTHERS

9 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY

  • 9.1 EUROPE
    • 9.1.1 GERMANY
    • 9.1.2 U.K.
    • 9.1.3 FRANCE
    • 9.1.4 ITALY
    • 9.1.5 SPAIN
    • 9.1.6 SWITZERLAND
    • 9.1.7 NETHERLANDS
    • 9.1.8 BELGIUM
    • 9.1.9 AUSTRIA
    • 9.1.10 IRELAND
    • 9.1.11 REST OF EUROPE

10 EUROPE PCR MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: EUROPE

11 SWOT ANALYSIS

  • 11.1 STRENGTH: - SIGNIFICANT INCREASING SHARES IN MARKET FOCUSED SEGMENT
  • 11.2 STRENGTH: - STRONG EUROPE PRESENCE AND MARKET SHARE
  • 11.3 WEAKNESS: - PRODUCT RECALL
  • 11.4 OPPORTUNITY: - STRATEGIC INVESTMENTS
  • 11.5 THREAT: - STIFF COMPETITION

12 COMPANY PROFILES

  • 12.1 F. HOFFMANN-LA ROCHE LTD.
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 HOL0GIC INC
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENTS
  • 12.3 LUMINEX CORPORATION.
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENTS
  • 12.4 BECTON, DICKINSON AND COMPANY
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 REVENUE ANALYSIS
    • 12.4.3 COMPANY SHARE ANALYSIS
    • 12.4.4 PRODUCT PORTFOLIO
    • 12.4.5 RECENT DEVELOPMENTS
  • 12.5 ABBOTT
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 REVENUE ANALYSIS
    • 12.5.3 PRODUCT PORTFOLIO
    • 12.5.4 RECENT DEVELOPMENTS
  • 12.6 AGENA BIOSCIENCE, INC
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 PRODUCT PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENT
  • 12.7 AGILENT TECHNOLOGIES, INC
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENT
  • 12.8 BIO-RAD LABORATORIES, INC.
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 REVENUE ANALYSIS
    • 12.8.3 PRODUCT PORTFOLIO
    • 12.8.4 RECENT DEVELOPMENTS
  • 12.9 BIOMERIEUX SA
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 REVENUE ANALYSIS
    • 12.9.3 PRODUCT PORTFOLIO
    • 12.9.4 RECENT DEVELOPMENTS
  • 12.10 BIOTEK INSTRUMENTS, INC.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENT
  • 12.11 DIASORIN S.P.A
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 REVENUE ANALYSIS
    • 12.11.3 PRODUCT PORTFOLIO
    • 12.11.4 RECENT DEVELOPMENT
  • 12.12 EUROFINS SCIENTIFIC
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 REVENUE ANALYSIS
    • 12.12.3 PRODUCT PORTFOLIO
    • 12.12.4 RECENT DEVELOPMENT
  • 12.13 ILLUMINA, INC.
    • 12.13.1 COMPANY SNAPSHOT
    • 12.13.2 REVENUE ANALYSIS
    • 12.13.3 PRODUCT PORTFOLIO
    • 12.13.4 RECENT DEVELOPMENT
  • 12.14 OLINK
    • 12.14.1 COMPANY SNAPSHOT
    • 12.14.2 PRODUCT PORTFOLIO
    • 12.14.3 RECENT DEVELOPMENT
  • 12.15 PATHONOSTICS B.V.
    • 12.15.1 COMPANY SNAPSHOT
    • 12.15.2 PRODUCT PORTFOLIO
    • 12.15.3 RECENT DEVELOPMENT
  • 12.16 PERKINELMER INC.
    • 12.16.1 COMPANY SNAPSHOT
    • 12.16.2 REVENUE ANALYSIS
    • 12.16.3 PRODUCT PORTFOLIO
    • 12.16.4 RECENT DEVELOPMENT
  • 12.17 QIAGEN
    • 12.17.1 COMPANY SNAPSHOT
    • 12.17.2 REVENUE ANALYSIS
    • 12.17.3 PRODUCT PORTFOLIO
    • 12.17.4 RECENT DEVELOPMENTS
  • 12.18 QUEST DIAGNOSTICS INCORPORATED
    • 12.18.1 COMPANY SNAPSHOT
    • 12.18.2 REVENUE ANALYSIS
    • 12.18.3 PRODUCT PORTFOLIO
    • 12.18.4 RECENT DEVELOPMENT
  • 12.19 RANDOX LABORATORIES LTD.
    • 12.19.1 COMPANY SNAPSHOT
    • 12.19.2 PRODUCT PORTFOLIO
    • 12.19.3 RECENT DEVELOPMENT
  • 12.20 SEEGENE INC.
    • 12.20.1 COMPANY SNAPSHOT
    • 12.20.2 REVENUE ANALYSIS
    • 12.20.3 PRODUCT PORTFOLIO
    • 12.20.4 RECENT DEVELOPMENT

  • 12.21 SIEMENS
    • 12.21.1 COMPANY SNAPSHOT
    • 12.21.2 REVENUE ANALYSIS
    • 12.21.3 PRODUCT PORTFOLIO
    • 12.21.4 RECENT DEVELOPMENTS
  • 12.22 SYSMEX CORPORATION
    • 12.22.1 COMPANY SNAPSHOT
    • 12.22.2 REVENUE ANALYSIS
    • 12.22.3 PRODUCT PORTFOLIO
    • 12.22.4 RECENT DEVELOPMENTS
  • 12.23 THERMO FISHER SCIENTIFIC INC.
    • 12.23.1 COMPANY SNAPSHOT
    • 12.23.2 REVENUE ANALYSIS
    • 12.23.3 PRODUCT PORTFOLIO
    • 12.23.4 RECENT DEVELOPMENT

13 CONCLUSION

14 QUESTIONNAIRE

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 RESEARCH AND DEVELOPMENT ACTIVITIES OF MAJOR BIO-PHARMA COMPANIES
  • TABLE 2 LIST OF HUMAN GENETIC TESTS
  • TABLE 3 THE COST OF THE FEW REAGENT USED IN THE PCR MULTIPLEX ASSAYS ARE;
  • TABLE 4 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 5 EUROPE REAGENTS & CONSUMABLES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 EUROPE INSTRUMENTS & ACCESSORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 EUROPE SOFTWARE AND SERVICES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 9 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 11 EUROPE RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 EUROPE RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 13 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 14 EUROPE HOSPITALS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 EUROPE CLINICAL LABORATORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 EUROPE RESEARCH INSTITUTES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 EUROPE OTHERS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 20 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 21 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 EUROPE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 23 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 EUROPE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 25 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 26 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 27 GERMANY CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 28 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 29 GERMANY PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 U.K. PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 31 U.K. PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 32 U.K. CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 33 U.K. PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 34 U.K. PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 35 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 36 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 37 FRANCE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 38 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 39 FRANCE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 40 ITALY PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 41 ITALY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 ITALY CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 ITALY PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 44 ITALY PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 45 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 46 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 47 SPAIN CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 48 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 49 SPAIN PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 50 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 51 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 SWITZERLAND CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 53 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 54 SWITZERLAND PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 55 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 56 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 57 NETHERLANDS CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 58 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 59 NETHERLANDS PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 60 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 61 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 62 BELGIUM CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 63 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 64 BELGIUM PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 65 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 67 AUSTRIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 68 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69 AUSTRIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 70 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 71 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 72 IRELAND CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 73 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 74 IRELAND PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 75 REST OF EUROPE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE PCR MULTIPLEX ASSAYS MARKET: SEGMENTATION
  • FIGURE 2 EUROPE PCR MULTIPLEX ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 EUROPE PCR MULTIPLEX ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE PCR MULTIPLEX ASSAYS MARKET: EUROPE VS REGIONAL ANALYSIS
  • FIGURE 5 EUROPE PCR MULTIPLEX ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE PCR MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE PCR MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 EUROPE PCR MULTIPLEX ASSAYS MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 EUROPE PCR MULTIPLEX ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PCR MULTIPLEX ASSAYS MARKET
  • FIGURE 11 EUROPE PCR MULTIPLEX ASSAYS MARKET: SEGMENTATION
  • FIGURE 12 TECHNOLOGICAL ADVANCEMENTS OF EUROPE PCR MULTIPLEX ASSAYS AND INTRODUCTION OF NOVEL AUTOMATED SYSTEMS ARE EXPECTED TO DRIVE THE EUROPE PCR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 13 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PCR MULTIPLEX ASSAYS MARKET IN 2019 & 2026
  • FIGURE 14 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES, 2018
  • FIGURE 15 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 16 EUROPE PCR MULTIPLEX ASSAYS MARKET : BY END USER, 2018
  • FIGURE 17 EUROPE PCR MULTIPLEX ASSAYS MARKET: SNAPSHOT (2018)
  • FIGURE 18 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018)
  • FIGURE 19 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 20 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 21 EUROPE PCR MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019-2026)
  • FIGURE 22 EUROPE PCR MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%)